Fluorine in PDB 6byz: Structure of Cysteine-Free Human Insulin-Degrading Enzyme in Complex with Substrate-Selective Macrocyclic Inhibitor 37
Enzymatic activity of Structure of Cysteine-Free Human Insulin-Degrading Enzyme in Complex with Substrate-Selective Macrocyclic Inhibitor 37
All present enzymatic activity of Structure of Cysteine-Free Human Insulin-Degrading Enzyme in Complex with Substrate-Selective Macrocyclic Inhibitor 37:
3.4.24.56;
Protein crystallography data
The structure of Structure of Cysteine-Free Human Insulin-Degrading Enzyme in Complex with Substrate-Selective Macrocyclic Inhibitor 37, PDB code: 6byz
was solved by
G.A.Tan,
M.A.Seeliger,
J.P.Maianti,
D.R.Liu,
with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:
Resolution Low / High (Å)
|
48.48 /
2.96
|
Space group
|
P 65
|
Cell size a, b, c (Å), α, β, γ (°)
|
264.486,
264.486,
91.094,
90.00,
90.00,
120.00
|
R / Rfree (%)
|
16.1 /
20.3
|
Fluorine Binding Sites:
The binding sites of Fluorine atom in the Structure of Cysteine-Free Human Insulin-Degrading Enzyme in Complex with Substrate-Selective Macrocyclic Inhibitor 37
(pdb code 6byz). This binding sites where shown within
5.0 Angstroms radius around Fluorine atom.
In total 6 binding sites of Fluorine where determined in the
Structure of Cysteine-Free Human Insulin-Degrading Enzyme in Complex with Substrate-Selective Macrocyclic Inhibitor 37, PDB code: 6byz:
Jump to Fluorine binding site number:
1;
2;
3;
4;
5;
6;
Fluorine binding site 1 out
of 6 in 6byz
Go back to
Fluorine Binding Sites List in 6byz
Fluorine binding site 1 out
of 6 in the Structure of Cysteine-Free Human Insulin-Degrading Enzyme in Complex with Substrate-Selective Macrocyclic Inhibitor 37
Mono view
Stereo pair view
|
A full contact list of Fluorine with other atoms in the F binding
site number 1 of Structure of Cysteine-Free Human Insulin-Degrading Enzyme in Complex with Substrate-Selective Macrocyclic Inhibitor 37 within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:F1101
b:0.1
occ:0.79
|
F01
|
A:J181101
|
0.0
|
0.1
|
0.8
|
C09
|
A:J181101
|
1.4
|
0.0
|
0.8
|
H10
|
A:J181101
|
2.1
|
90.7
|
0.8
|
F03
|
A:J181101
|
2.2
|
0.8
|
0.8
|
F02
|
A:J181101
|
2.2
|
0.8
|
0.8
|
C08
|
A:J181101
|
2.3
|
86.2
|
0.8
|
C10
|
A:J181101
|
2.5
|
75.6
|
0.8
|
CA
|
D:ALA3
|
2.9
|
94.4
|
1.0
|
C
|
A:GLY361
|
3.3
|
45.5
|
1.0
|
O
|
A:GLY361
|
3.3
|
53.1
|
1.0
|
N
|
D:ALA3
|
3.4
|
93.9
|
1.0
|
CB
|
D:ALA3
|
3.5
|
92.0
|
1.0
|
N
|
A:GLY362
|
3.6
|
45.9
|
1.0
|
C07
|
A:J181101
|
3.6
|
77.2
|
0.8
|
CA
|
A:GLY361
|
3.8
|
43.7
|
1.0
|
N
|
A:GLY361
|
3.9
|
45.0
|
1.0
|
C11
|
A:J181101
|
3.9
|
69.6
|
0.8
|
CA
|
A:GLY362
|
4.0
|
44.3
|
1.0
|
C
|
D:ALA3
|
4.0
|
92.7
|
1.0
|
C
|
D:ALA2
|
4.1
|
83.5
|
1.0
|
C
|
A:GLY362
|
4.2
|
40.8
|
1.0
|
O
|
A:GLY362
|
4.3
|
31.4
|
1.0
|
CG2
|
A:ILE374
|
4.4
|
35.3
|
1.0
|
O
|
D:ALA2
|
4.4
|
75.6
|
1.0
|
H11
|
A:J181101
|
4.5
|
83.5
|
0.8
|
CG2
|
A:VAL360
|
4.5
|
36.8
|
1.0
|
C
|
A:VAL360
|
4.5
|
45.6
|
1.0
|
O
|
A:GLN363
|
4.7
|
40.4
|
1.0
|
C13
|
A:J181101
|
4.7
|
68.3
|
0.8
|
O
|
D:ALA3
|
4.7
|
89.0
|
1.0
|
CB
|
A:VAL360
|
4.7
|
38.4
|
1.0
|
S01
|
A:J181101
|
4.7
|
81.8
|
0.8
|
O02
|
A:J181101
|
4.8
|
77.7
|
0.8
|
C12
|
A:J181101
|
4.8
|
67.5
|
0.8
|
N
|
A:GLN363
|
4.9
|
39.2
|
1.0
|
O
|
D:ALA1
|
5.0
|
79.1
|
1.0
|
O
|
D:HOH101
|
5.0
|
62.0
|
1.0
|
O
|
A:ILE374
|
5.0
|
41.6
|
1.0
|
O03
|
A:J181101
|
5.0
|
83.3
|
0.8
|
O
|
A:VAL360
|
5.0
|
45.6
|
1.0
|
|
Fluorine binding site 2 out
of 6 in 6byz
Go back to
Fluorine Binding Sites List in 6byz
Fluorine binding site 2 out
of 6 in the Structure of Cysteine-Free Human Insulin-Degrading Enzyme in Complex with Substrate-Selective Macrocyclic Inhibitor 37
Mono view
Stereo pair view
|
A full contact list of Fluorine with other atoms in the F binding
site number 2 of Structure of Cysteine-Free Human Insulin-Degrading Enzyme in Complex with Substrate-Selective Macrocyclic Inhibitor 37 within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:F1101
b:0.8
occ:0.79
|
F02
|
A:J181101
|
0.0
|
0.8
|
0.8
|
C09
|
A:J181101
|
1.3
|
0.0
|
0.8
|
F03
|
A:J181101
|
2.2
|
0.8
|
0.8
|
F01
|
A:J181101
|
2.2
|
0.1
|
0.8
|
C08
|
A:J181101
|
2.3
|
86.2
|
0.8
|
C07
|
A:J181101
|
2.9
|
77.2
|
0.8
|
CG2
|
A:ILE374
|
2.9
|
35.3
|
1.0
|
O03
|
A:J181101
|
3.0
|
83.3
|
0.8
|
S01
|
A:J181101
|
3.2
|
81.8
|
0.8
|
C10
|
A:J181101
|
3.4
|
75.6
|
0.8
|
CG2
|
A:VAL360
|
3.4
|
36.8
|
1.0
|
O02
|
A:J181101
|
3.5
|
77.7
|
0.8
|
H10
|
A:J181101
|
3.6
|
90.7
|
0.8
|
CA
|
A:GLY361
|
3.9
|
43.7
|
1.0
|
O
|
A:VAL360
|
3.9
|
45.6
|
1.0
|
N
|
A:GLY361
|
3.9
|
45.0
|
1.0
|
C
|
A:VAL360
|
3.9
|
45.6
|
1.0
|
C
|
A:GLY361
|
4.1
|
45.5
|
1.0
|
O
|
A:ILE374
|
4.2
|
41.6
|
1.0
|
C13
|
A:J181101
|
4.2
|
68.3
|
0.8
|
CB
|
A:VAL360
|
4.2
|
38.4
|
1.0
|
N
|
A:GLY362
|
4.3
|
45.9
|
1.0
|
CB
|
A:ILE374
|
4.4
|
48.3
|
1.0
|
C11
|
A:J181101
|
4.5
|
69.6
|
0.8
|
C
|
A:ILE374
|
4.6
|
44.8
|
1.0
|
O
|
A:GLY361
|
4.6
|
53.1
|
1.0
|
N02
|
A:J181101
|
4.7
|
79.0
|
0.8
|
CA
|
A:VAL360
|
4.8
|
41.1
|
1.0
|
CB
|
A:ASN376
|
4.8
|
75.0
|
1.0
|
O
|
A:GLY362
|
4.8
|
31.4
|
1.0
|
C12
|
A:J181101
|
4.9
|
67.5
|
0.8
|
O
|
A:HOH1382
|
4.9
|
78.5
|
1.0
|
H13
|
A:J181101
|
4.9
|
82.0
|
0.8
|
H31
|
A:J181101
|
5.0
|
89.6
|
0.8
|
|
Fluorine binding site 3 out
of 6 in 6byz
Go back to
Fluorine Binding Sites List in 6byz
Fluorine binding site 3 out
of 6 in the Structure of Cysteine-Free Human Insulin-Degrading Enzyme in Complex with Substrate-Selective Macrocyclic Inhibitor 37
Mono view
Stereo pair view
|
A full contact list of Fluorine with other atoms in the F binding
site number 3 of Structure of Cysteine-Free Human Insulin-Degrading Enzyme in Complex with Substrate-Selective Macrocyclic Inhibitor 37 within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:F1101
b:0.8
occ:0.79
|
F03
|
A:J181101
|
0.0
|
0.8
|
0.8
|
C09
|
A:J181101
|
1.3
|
0.0
|
0.8
|
F02
|
A:J181101
|
2.2
|
0.8
|
0.8
|
F01
|
A:J181101
|
2.2
|
0.1
|
0.8
|
C08
|
A:J181101
|
2.2
|
86.2
|
0.8
|
O02
|
A:J181101
|
2.9
|
77.7
|
0.8
|
CG2
|
A:VAL360
|
3.0
|
36.8
|
1.0
|
C07
|
A:J181101
|
3.0
|
77.2
|
0.8
|
C10
|
A:J181101
|
3.3
|
75.6
|
0.8
|
S01
|
A:J181101
|
3.4
|
81.8
|
0.8
|
CB
|
A:VAL360
|
3.4
|
38.4
|
1.0
|
H10
|
A:J181101
|
3.5
|
90.7
|
0.8
|
O03
|
A:J181101
|
4.0
|
83.3
|
0.8
|
CA
|
D:ALA3
|
4.1
|
94.4
|
1.0
|
O
|
D:HOH101
|
4.1
|
62.0
|
1.0
|
C13
|
A:J181101
|
4.2
|
68.3
|
0.8
|
N
|
A:GLY361
|
4.3
|
45.0
|
1.0
|
C
|
A:VAL360
|
4.3
|
45.6
|
1.0
|
CG1
|
A:VAL360
|
4.4
|
41.2
|
1.0
|
C11
|
A:J181101
|
4.5
|
69.6
|
0.8
|
C
|
D:ALA3
|
4.5
|
92.7
|
1.0
|
CA
|
A:VAL360
|
4.5
|
41.1
|
1.0
|
O
|
D:ALA2
|
4.6
|
75.6
|
1.0
|
N
|
D:ALA3
|
4.6
|
93.9
|
1.0
|
O
|
A:VAL360
|
4.7
|
45.6
|
1.0
|
CA
|
A:GLY361
|
4.8
|
43.7
|
1.0
|
O
|
A:GLY361
|
4.8
|
53.1
|
1.0
|
N02
|
A:J181101
|
4.8
|
79.0
|
0.8
|
C
|
A:GLY361
|
4.8
|
45.5
|
1.0
|
C
|
D:ALA2
|
4.8
|
83.5
|
1.0
|
C12
|
A:J181101
|
4.9
|
67.5
|
0.8
|
|
Fluorine binding site 4 out
of 6 in 6byz
Go back to
Fluorine Binding Sites List in 6byz
Fluorine binding site 4 out
of 6 in the Structure of Cysteine-Free Human Insulin-Degrading Enzyme in Complex with Substrate-Selective Macrocyclic Inhibitor 37
Mono view
Stereo pair view
|
A full contact list of Fluorine with other atoms in the F binding
site number 4 of Structure of Cysteine-Free Human Insulin-Degrading Enzyme in Complex with Substrate-Selective Macrocyclic Inhibitor 37 within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
B:F1101
b:0.3
occ:0.70
|
F01
|
B:J181101
|
0.0
|
0.3
|
0.7
|
C09
|
B:J181101
|
1.3
|
0.3
|
0.7
|
F02
|
B:J181101
|
2.1
|
0.5
|
0.7
|
F03
|
B:J181101
|
2.2
|
0.4
|
0.7
|
C08
|
B:J181101
|
2.2
|
89.2
|
0.7
|
H10
|
B:J181101
|
2.6
|
95.9
|
0.7
|
C10
|
B:J181101
|
2.7
|
79.9
|
0.7
|
CA
|
E:ALA3
|
2.9
|
0.3
|
1.0
|
C
|
E:ALA3
|
3.1
|
96.2
|
1.0
|
C07
|
B:J181101
|
3.3
|
80.7
|
0.7
|
O
|
E:ALA2
|
3.6
|
0.6
|
1.0
|
N
|
E:ALA3
|
3.7
|
0.6
|
1.0
|
O02
|
B:J181101
|
3.9
|
71.9
|
0.7
|
C
|
E:ALA2
|
3.9
|
0.8
|
1.0
|
CB
|
B:VAL360
|
4.0
|
50.2
|
1.0
|
C11
|
B:J181101
|
4.0
|
77.3
|
0.7
|
CB
|
E:ALA3
|
4.1
|
0.1
|
1.0
|
CG2
|
B:VAL360
|
4.1
|
47.9
|
1.0
|
O
|
E:ALA3
|
4.2
|
90.7
|
1.0
|
S01
|
B:J181101
|
4.2
|
76.8
|
0.7
|
O
|
B:GLY361
|
4.4
|
44.7
|
1.0
|
C13
|
B:J181101
|
4.5
|
75.5
|
0.7
|
N
|
B:GLY361
|
4.5
|
50.6
|
1.0
|
CD1
|
B:ILE374
|
4.6
|
58.2
|
1.0
|
C
|
B:GLY361
|
4.7
|
45.4
|
1.0
|
C12
|
B:J181101
|
4.7
|
75.2
|
0.7
|
H11
|
B:J181101
|
4.7
|
92.8
|
0.7
|
C
|
B:VAL360
|
4.8
|
55.5
|
1.0
|
O03
|
B:J181101
|
4.9
|
80.2
|
0.7
|
CG1
|
B:VAL360
|
4.9
|
52.4
|
1.0
|
CA
|
B:GLY361
|
5.0
|
46.3
|
1.0
|
CA
|
B:VAL360
|
5.0
|
53.3
|
1.0
|
|
Fluorine binding site 5 out
of 6 in 6byz
Go back to
Fluorine Binding Sites List in 6byz
Fluorine binding site 5 out
of 6 in the Structure of Cysteine-Free Human Insulin-Degrading Enzyme in Complex with Substrate-Selective Macrocyclic Inhibitor 37
Mono view
Stereo pair view
|
A full contact list of Fluorine with other atoms in the F binding
site number 5 of Structure of Cysteine-Free Human Insulin-Degrading Enzyme in Complex with Substrate-Selective Macrocyclic Inhibitor 37 within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
B:F1101
b:0.5
occ:0.70
|
F02
|
B:J181101
|
0.0
|
0.5
|
0.7
|
C09
|
B:J181101
|
1.3
|
0.3
|
0.7
|
F01
|
B:J181101
|
2.1
|
0.3
|
0.7
|
F03
|
B:J181101
|
2.1
|
0.4
|
0.7
|
C08
|
B:J181101
|
2.2
|
89.2
|
0.7
|
H10
|
B:J181101
|
2.5
|
95.9
|
0.7
|
C10
|
B:J181101
|
2.7
|
79.9
|
0.7
|
CD1
|
B:ILE374
|
2.8
|
58.2
|
1.0
|
C
|
B:GLY361
|
3.2
|
45.4
|
1.0
|
CA
|
B:GLY361
|
3.4
|
46.3
|
1.0
|
O
|
B:GLY361
|
3.4
|
44.7
|
1.0
|
C07
|
B:J181101
|
3.4
|
80.7
|
0.7
|
N
|
B:GLY361
|
3.5
|
50.6
|
1.0
|
CA
|
E:ALA3
|
3.5
|
0.3
|
1.0
|
N
|
B:GLY362
|
3.5
|
50.4
|
1.0
|
C
|
B:VAL360
|
3.9
|
55.5
|
1.0
|
C11
|
B:J181101
|
4.0
|
77.3
|
0.7
|
CG1
|
B:ILE374
|
4.1
|
57.2
|
1.0
|
N
|
E:ALA3
|
4.1
|
0.6
|
1.0
|
CB
|
E:ALA3
|
4.2
|
0.1
|
1.0
|
CA
|
B:GLY362
|
4.2
|
53.1
|
1.0
|
O
|
B:VAL360
|
4.3
|
58.8
|
1.0
|
CG2
|
B:VAL360
|
4.3
|
47.9
|
1.0
|
O
|
B:ILE374
|
4.3
|
49.9
|
1.0
|
S01
|
B:J181101
|
4.3
|
76.8
|
0.7
|
CB
|
B:VAL360
|
4.3
|
50.2
|
1.0
|
O
|
B:GLY362
|
4.3
|
46.5
|
1.0
|
O03
|
B:J181101
|
4.4
|
80.2
|
0.7
|
C
|
E:ALA3
|
4.4
|
96.2
|
1.0
|
C
|
B:GLY362
|
4.4
|
49.2
|
1.0
|
O02
|
B:J181101
|
4.5
|
71.9
|
0.7
|
C13
|
B:J181101
|
4.5
|
75.5
|
0.7
|
H11
|
B:J181101
|
4.7
|
92.8
|
0.7
|
C
|
E:ALA2
|
4.7
|
0.8
|
1.0
|
CA
|
B:VAL360
|
4.7
|
53.3
|
1.0
|
C12
|
B:J181101
|
4.8
|
75.2
|
0.7
|
O
|
E:ALA2
|
4.9
|
0.6
|
1.0
|
|
Fluorine binding site 6 out
of 6 in 6byz
Go back to
Fluorine Binding Sites List in 6byz
Fluorine binding site 6 out
of 6 in the Structure of Cysteine-Free Human Insulin-Degrading Enzyme in Complex with Substrate-Selective Macrocyclic Inhibitor 37
Mono view
Stereo pair view
|
A full contact list of Fluorine with other atoms in the F binding
site number 6 of Structure of Cysteine-Free Human Insulin-Degrading Enzyme in Complex with Substrate-Selective Macrocyclic Inhibitor 37 within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
B:F1101
b:0.4
occ:0.70
|
F03
|
B:J181101
|
0.0
|
0.4
|
0.7
|
C09
|
B:J181101
|
1.3
|
0.3
|
0.7
|
F02
|
B:J181101
|
2.1
|
0.5
|
0.7
|
F01
|
B:J181101
|
2.2
|
0.3
|
0.7
|
C08
|
B:J181101
|
2.2
|
89.2
|
0.7
|
O02
|
B:J181101
|
2.4
|
71.9
|
0.7
|
C07
|
B:J181101
|
2.7
|
80.7
|
0.7
|
S01
|
B:J181101
|
2.7
|
76.8
|
0.7
|
CG2
|
B:VAL360
|
2.8
|
47.9
|
1.0
|
O03
|
B:J181101
|
3.0
|
80.2
|
0.7
|
CB
|
B:VAL360
|
3.4
|
50.2
|
1.0
|
CD1
|
B:ILE374
|
3.4
|
58.2
|
1.0
|
C10
|
B:J181101
|
3.5
|
79.9
|
0.7
|
H10
|
B:J181101
|
3.8
|
95.9
|
0.7
|
ND2
|
B:ASN376
|
3.8
|
1.0
|
1.0
|
C
|
B:VAL360
|
4.0
|
55.5
|
1.0
|
C13
|
B:J181101
|
4.1
|
75.5
|
0.7
|
O
|
B:VAL360
|
4.2
|
58.8
|
1.0
|
N
|
B:GLY361
|
4.2
|
50.6
|
1.0
|
N02
|
B:J181101
|
4.3
|
70.5
|
0.7
|
CA
|
B:VAL360
|
4.3
|
53.3
|
1.0
|
CG
|
B:ASN376
|
4.5
|
97.9
|
1.0
|
CG1
|
B:VAL360
|
4.6
|
52.4
|
1.0
|
C11
|
B:J181101
|
4.6
|
77.3
|
0.7
|
CA
|
B:GLY361
|
4.7
|
46.3
|
1.0
|
H08
|
B:J181101
|
4.7
|
79.5
|
0.7
|
H13
|
B:J181101
|
4.7
|
90.5
|
0.7
|
CG1
|
B:ILE374
|
4.8
|
57.2
|
1.0
|
C12
|
B:J181101
|
4.9
|
75.2
|
0.7
|
CB
|
B:ASN376
|
4.9
|
78.2
|
1.0
|
CA
|
E:ALA3
|
4.9
|
0.3
|
1.0
|
C06
|
B:J181101
|
5.0
|
66.1
|
0.7
|
C
|
B:GLY361
|
5.0
|
45.4
|
1.0
|
H1A
|
B:J181101
|
5.0
|
79.3
|
0.7
|
|
Reference:
J.P.Maianti,
G.A.Tan,
A.Vetere,
A.J.Welsh,
B.K.Wagner,
M.A.Seeliger,
D.R.Liu.
Substrate-Selective Inhibitors That Reprogram the Activity of Insulin-Degrading Enzyme. Nat.Chem.Biol. V. 15 565 2019.
ISSN: ESSN 1552-4469
PubMed: 31086331
DOI: 10.1038/S41589-019-0271-0
Page generated: Thu Aug 1 18:24:17 2024
|